Medicine sales value share in Russia 2020-2023, by origin
In 2023, pharmaceuticals of foreign origin comprised the largest share of Russian pharmaceutical commercial sales of medicines in monetary terms, at 51.9 percent. The share of revenue from domestic drug sales slightly increased from the previous year.